Ophthalmic Topical Therapeutics Market Research Report Information by Product Type (Artificial Tears, Anti-allergy, Antibiotic Drops, Anti-Inflammatory, Antiglaucoma, and Others), by Disease Type (Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, Uveitis, and Others), by Dosage Type (Eye Drops, Gels, Ointments, and Others), by Distribution Channel (Hospital Pharmacies, Drug Stores, Online Pharmacies, and Others) and Region (North America, Europe, Asia-Pacific, and Rest of the World - Forecast till 2032

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 RISE IN GERIATRIC POPULATION

4.2.2 INCREASING PREVALENCE OF OPHTHALMIC DISORDERS

4.3 RESTRAINTS

4.3.1 LACK OF AWARENESS REGARDING EYE DISORDERS

4.4 OPPORTUNITIES

4.4.1 GROWING NUMBER OF TOPICAL DRUGS IN THE PIPELINE

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION & SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE OPHTHALMIC TOPICAL THERAPEUTICS MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON PRODUCTTION

5.3.3 IMPACT ON MARKET PLAYERS

6 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY PRODUCT TYPE

6.1 OVERVIEW

6.2 ARTIFICIAL TEARS

6.3 ANTI-ALLERGY

6.4 ANTIBIOTIC DROPS

6.5 ANTI-INFLAMMATORY

6.6 ANTIGLAUCOMA

6.7 OTHERS

7 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE

7.1 OVERVIEW

7.2 DRY EYE

7.3 EYE ALLERGY

7.4 GLAUCOMA

7.5 EYE INFECTION

7.6 RETINAL DISORDERS

7.7 UVEITIS

7.8 OTHERS

8 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM

8.1 OVERVIEW

8.2 EYE DROPS

8.3 GELS

8.4 OINTMENTS

8.5 OTHERS

9 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL

9.1 OVERVIEW

9.2 HOSPITAL PHARMACIES

9.3 DRUG STORES

9.4 ONLINE PHARMACIES

9.5 OTHERS

10 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY REGION

10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 US

10.2.2 CANADA

10.3 EUROPE

10.3.1 GERMANY

10.3.2 UK

10.3.3 FRANCE

10.3.4 ITALY

10.3.5 SPAIN

10.3.6 REST OF EUROPE

10.4 ASIA-PACIFIC

10.4.1 JAPAN

10.4.2 CHINA

10.4.3 INDIA

10.4.4 AUSTRALIA

10.4.5 SOUTH KOREA

10.4.6 REST OF ASIA-PACIFIC

10.5 REST OF THE WORLD

10.5.1 MIDDLE EAST

10.5.2 AFRICA

10.5.3 LATIN AMERICA

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW

11.2 COMPETITIVE BENCHMARKING

11.3 MAJOR GROWTH STRATEGY IN GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET

11.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET

11.5 KEY DEVELOPMENT ANALYSIS

11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

11.6.1 PRODUCT APPROVALS AND PRODUCT LAUNCHES/PIPELINE DRUGS

11.6.2 PARTNERSHIP/COLLABORATION

11.6.3 BUSINESS EXPANSIONS/AGREEMENTS

11.6.4 MERGERS & ACQUISITIONS

11.7 MAJOR PLAYERS SALES ANALYSIS

11.7.1 SALES & OPERATING INCOME

11.8 MAJOR PLAYERS R&D ANALYSIS

12 COMPANY PROFILES

12.1 SANTEN PHARMACEUTICAL CO., LTD.

12.1.1 COMPANY OVERVIEW

12.1.2 FINANCIAL OVERVIEW

12.1.3 PRODUCTS/SERVICES OFFERED

12.1.4 KEY DEVELOPMENTS

12.1.5 KEY STRATEGIES

12.2 SUN PHARMACEUTICAL INDUSTRIES LTD

12.2.1 COMPANY OVERVIEW

12.2.2 FINANCIAL OVERVIEW

12.2.3 PRODUCTS/SERVICES OFFERED

12.2.4 KEY DEVELOPMENTS

12.2.5 KEY STRATEGIES

12.3 NOVARTIS AG

12.3.1 COMPANY OVERVIEWS

12.3.2 FINANCIAL OVERVIEW

12.3.3 PRODUCTS/SERVICES OFFERED

12.3.4 KEY DEVELOPMENTS

12.3.5 SWOT ANALYSIS

12.3.6 KEY STRATEGIES

12.4 ABBVIE INC.

12.4.1 COMPANY OVERVIEW

12.4.2 FINANCIAL OVERVIEW

12.4.3 PRODUCTS OFFERED

12.4.4 KEY DEVELOPMENTS

12.4.5 SWOT ANALYSIS

12.4.6 KEY STRATEGIES

12.5 BAUSCH & LOMB INCORPORATED

12.5.1 COMPANY OVERVIEW

12.5.2 FINANCIAL OVERVIEW

12.5.3 PRODUCTS OFFERED

12.5.4 KEY DEVELOPMENTS

12.5.5 SWOT ANALYSIS

12.5.6 KEY STRATEGIES

12.6 AMNEAL PHARMACEUTICALS LLC.

12.6.1 COMPANY OVERVIEW

12.6.2 FINANCIAL OVERVIEW

12.6.3 PRODUCTS/SERVICES OFFERED

12.6.4 KEY DEVELOPMENTS

12.6.5 KEY STRATEGIES

12.7 TEVA PHARMACEUTICAL INDUSTRIES LTD.

12.7.1 COMPANY OVERVIEW

12.7.2 FINANCIAL ANALYSIS

12.7.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED

12.7.4 KEY DEVELOPMENTS

12.7.5 SWOT ANALYSIS

12.7.6 KEY STRATEGIES

12.8 ALCON

12.8.1 COMPANY OVERVIEW

12.8.2 FINANCIAL OVERVIEW

12.8.3 PRODUCTS/SERVICES/SOLUTIONS 0FFERED

12.8.4 KEY DEVELOPMENTS

12.8.5 SWOT ANALYSIS

12.8.6 KEY STRATEGIES

12.9 AKORN OPERATING COMPANY LLC

12.9.1 COMPANY OVERVIEW

12.9.2 FINANCIAL OVERVIEW

12.9.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED

12.9.4 KEY DEVELOPMENTS

12.9.5 KEY STRATEGIES

12.10 VIATRIS INC.

12.10.1 COMPANY OVERVIEW

12.10.2 FINANCIAL OVERVIEW

12.10.3 PRODUCTS/SERVICES OFFERED

12.10.4 KEY DEVELOPMENTS

12.10.5 KEY STRATEGIES

13 APPENDIX

13.1 REFERENCES

13.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 4 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR ARTIFICIAL TEARS, BY REGION, 2019–2032 (USD BILLION)

TABLE 5 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR ANTI-ALLERGY, BY REGION, 2019–2032 (USD BILLION)

TABLE 6 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR ANTIBIOTIC DROPS, BY REGION, 2019–2032 (USD BILLION)

TABLE 7 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR ANTI-INFLAMMATORY, BY REGION, 2019–2032 (USD BILLION)

TABLE 8 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR ANTIGLAUCOMA, BY REGION, 2019–2032 (USD BILLION)

TABLE 9 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)

TABLE 10 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE, 2019–2032 (USD BILLION)

TABLE 11 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR DRY EYE, BY REGION, 2019–2032 (USD BILLION)

TABLE 12 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR EYE ALLERGY, BY REGION, 2019–2032 (USD BILLION)

TABLE 13 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR GLAUCOMA, BY REGION, 2019–2032 (USD BILLION)

TABLE 14 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR EYE INFECTION, BY REGION, 2019–2032 (USD BILLION)

TABLE 15 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR RETINAL DISORDERS, BY REGION, 2019–2032 (USD BILLION)

TABLE 16 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR UVEITIS, BY REGION, 2019–2032 (USD BILLION)

TABLE 17 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)

TABLE 18 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM, 2019–2032 (USD BILLION)

TABLE 19 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR EYE DROPS, BY REGION, 2019–2032 (USD BILLION)

TABLE 20 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR GELS, BY REGION, 2019–2032 (USD BILLION)

TABLE 21 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR OINTMENTS, BY REGION, 22019–2032 (USD BILLION)

TABLE 22 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)

TABLE 23 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 24 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2019–2032 (USD BILLION)

TABLE 25 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR DRUG STORES, BY REGION, 2019–2032 (USD BILLION)

TABLE 26 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR ONLINE PHARMACIES, BY REGION, 2019–2032 (USD BILLION)

TABLE 27 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)

TABLE 28 GLOBAL: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY REGION, 2019–2032 (USD BILLION)

TABLE 29 NORTH AMERICA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2032 (USD BILLION)

TABLE 30 NORTH AMERICA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 31 NORTH AMERICA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE, 2019-2032 (USD BILLION)

TABLE 32 NORTH AMERICA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM, 2019-2032 (USD BILLION)

TABLE 33 NORTH AMERICA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)

TABLE 34 US: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 35 US: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE, 2019-2032 (USD BILLION)

TABLE 36 US: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM, 2019-2032 (USD BILLION)

TABLE 37 US: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)

TABLE 38 CANADA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 39 CANADA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE, 2019-2032 (USD BILLION)

TABLE 40 CANADA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM, 2019-2032 (USD BILLION)

TABLE 41 CANADA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)

TABLE 42 EUROPE: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY COUNTRY, 2019–2032 (USD BILLION)

TABLE 43 EUROPE: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 44 EUROPE: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE, 2019-2032 (USD BILLION)

TABLE 45 EUROPE: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM, 2019-2032 (USD BILLION)

TABLE 46 EUROPE: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)

TABLE 47 GERMANY: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 48 GERMANY: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE, 2019-2032 (USD BILLION)

TABLE 49 GERMANY: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM, 2019-2032 (USD BILLION)

TABLE 50 GERMANY: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)

TABLE 51 UK: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 52 UK: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE, 2019-2032 (USD BILLION)

TABLE 53 UK: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM, 2019-2032 (USD BILLION)

TABLE 54 UK: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)

TABLE 55 FRANCE: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 56 FRANCE: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE, 2019-2032 (USD BILLION)

TABLE 57 FRANCE: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM, 2019-2032 (USD BILLION)

TABLE 58 FRANCE: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)

TABLE 59 ITALY: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 60 ITALY: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE, 2019-2032 (USD BILLION)

TABLE 61 ITALY: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM, 2019-2032 (USD BILLION)

TABLE 62 ITALY: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)

TABLE 63 SPAIN: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 64 SPAIN: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE, 2019-2032 (USD BILLION)

TABLE 65 SPAIN: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM, 2019-2032 (USD BILLION)

TABLE 66 SPAIN: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)

TABLE 67 REST OF EUROPE: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 68 REST OF EUROPE: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE, 2019-2032 (USD BILLION)

TABLE 69 REST OF EUROPE: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM, 2019-2032 (USD BILLION)

TABLE 70 REST OF EUROPE: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)

TABLE 71 ASIA-PACIFIC: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY COUNTRY, 2019–2032 (USD BILLION)

TABLE 72 ASIA-PACIFIC: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 73 ASIA-PACIFIC: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE, 2019–2032 (USD BILLION)

TABLE 74 ASIA-PACIFIC: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM, 2019–2032 (USD BILLION)

TABLE 75 ASIA-PACIFIC: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 76 JAPAN: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DEVICE TYPE, 2019-2032(USD BILLION)

TABLE 77 JAPAN: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE, 2019-2032(USD BILLION)

TABLE 78 JAPAN: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM, 2019-2032(USD BILLION)

TABLE 79 JAPAN: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)

TABLE 80 CHINA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DEVICE TYPE, 2019-2032(USD BILLION)

TABLE 81 CHINA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE, 2019-2032(USD BILLION)

TABLE 82 CHINA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM, 2019-2032(USD BILLION)

TABLE 83 CHINA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)

TABLE 84 INDIA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DEVICE TYPE, 2019-2032(USD BILLION)

TABLE 85 INDIA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE, 2019-2032(USD BILLION)

TABLE 86 INDIA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM, 2019-2032(USD BILLION)

TABLE 87 INDIA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)

TABLE 88 AUSTRALIA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DEVICE TYPE, 2019-2032(USD BILLION)

TABLE 89 AUSTRALIA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE, 2019-2032 (USD BILLION)

TABLE 90 AUSTRALIA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM, 2019-2032(USD BILLION)

TABLE 91 AUSTRALIA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2032(USD BILLION)

TABLE 92 SOUTH KOREA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DEVICE TYPE, 2019-2032 (USD BILLION)

TABLE 93 SOUTH KOREA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE, 2019-2032 (USD BILLION)

TABLE 94 SOUTH KOREA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM, 2019-2032 (USD BILLION)

TABLE 95 SOUTH KOREA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2032(USD BILLION)

TABLE 96 REST OF ASIA-PACIFIC: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DEVICE TYPE, 2019-2032(USD BILLION)

TABLE 97 REST OF ASIA-PACIFIC: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE, 2019-2032(USD BILLION)

TABLE 98 REST OF ASIA-PACIFIC: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM, 2019-2032(USD BILLION)

TABLE 99 REST OF ASIA-PACIFIC: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2032(USD BILLION)

TABLE 100 REST OF THE WORLD: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY COUNTRY 2019-2032(USD BILLION)

TABLE 101 REST OF THE WORLD: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY PRODUCT TYPE 2019-2032(USD BILLION)

TABLE 102 REST OF THE WORLD: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE 2019-2032(USD BILLION)

TABLE 103 REST OF THE WORLD: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM 2019-2032(USD BILLION)

TABLE 104 REST OF THE WORLD: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL 2019-2032(USD BILLION)

TABLE 105 MIDDLE EAST: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY PRODUCT TYPE 2019-2032 (USD BILLION)

TABLE 106 MIDDLE EAST: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE 2019-2032 (USD BILLION)

TABLE 107 MIDDLE EAST: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM 2019-2032(USD BILLION)

TABLE 108 MIDDLE EAST: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL 2019-2032(USD BILLION)

TABLE 109 AFRICA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY PRODUCT TYPE 2019-2032 (USD BILLION)

TABLE 110 AFRICA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE 2019-2032(USD BILLION)

TABLE 111 AFRICA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM 2019-2032(USD BILLION)

TABLE 112 AFRICA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL 2019-2032 (USD BILLION)

TABLE 113 LATIN AMERICA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY PRODUCT TYPE 2019-2032 (USD BILLION)

TABLE 114 LATIN AMERICA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE 2019-2032 (USD BILLION)

TABLE 115 LATIN AMERICA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM 2019-2032 (USD BILLION)

TABLE 116 LATIN AMERICA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL 2019-2032(USD BILLION)

TABLE 117 MAJOR MANUFACTURERS IN GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET

TABLE 118 MOST ACTIVE PLAYER IN GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET

TABLE 119 PRODUCT APPROVALS AND PRODUCT LAUNCHES/PIPELINE DRUGS

TABLE 120 PARTNERSHIP/COLLABORATION

TABLE 121 BUSINESS EXPANSIONS/ AGREEMENTS

TABLE 122 MERGERS & ACQUISITIONS

TABLE 123 SANTEN PHARMACEUTICAL CO., LTD.: PRODUCTS OFFERED

TABLE 124 SANTEN PHARMACEUTICAL CO., LTD.: KEY DEVELOPMENTS

TABLE 125 SUN PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS OFFERED

TABLE 126 GENENTECH, INC.: KEY DEVELOPMENTS

TABLE 127 NOVARTIS AG: PRODUCTS OFFERED

TABLE 128 NOVARTIS AG.: KEY DEVELOPMENTS

TABLE 129 ABBVIE INC.: PRODUCTS OFFERED

TABLE 130 ABBVIE INC.: KEY DEVELOPMENTS

TABLE 131 BAUSCH & LOMB INCORPORATED: PRODUCTS OFFERED

TABLE 132 BAUSCH & LOMB INCORPORATED: KEY DEVELOPMENTS

TABLE 133 AMNEAL PHARMACEUTICALS LLC.: PRODUCTS OFFERED

TABLE 134 AMNEAL PHARMACEUTICALS., LLC.: KEY DEVELOPMENTS

TABLE 135 TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED

TABLE 136 TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY DEVELOPMENTS

TABLE 137 ALCON: PRODUCTS/SERVICES/SOLUTIONS OFFERED

TABLE 138 ALCON: KEY DEVELOPMENTS

TABLE 139 AKORN OPERATING COMPANY LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED

TABLE 140 VIATRIS INC.: PRODUCTS/SERVICES OFFERED

TABLE 141 VIATRIS INC.: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: OPHTHALMIC TOPICAL THERAPEUTICS MARKET

FIGURE 5 DRIVERS: IMPACT ANALYSIS

FIGURE 6 RESTRAINT: IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET

FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET

FIGURE 9 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2022 & 2032 (USD BILLION)

FIGURE 10 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET SHARE (%), BY PRODUCT TYPE, 2022

FIGURE 11 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISEASE TYPE, 2022 & 2032 (USD BILLION)

FIGURE 12 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET SHARE (%), BY DISEASE TYPE, 2022

FIGURE 13 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DOSAGE FORM, 2022 & 2032 (USD BILLION)

FIGURE 14 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET SHARE (%), BY DOSAGE FORM, 2022

FIGURE 15 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2032 (USD BILLION)

FIGURE 16 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET SHARE (%), BY DISTRIBUTION CHANNEL, 2021

FIGURE 17 GLOBAL: OPHTHALMIC TOPICAL THERAPEUTICS MARKET, BY REGION 2022 & 2032 (USD BILLION)

FIGURE 18 GLOBAL: OPHTHALMIC TOPICAL THERAPEUTICS MARKET SHARE (%), BY REGION 2022

FIGURE 19 NORTH AMERICA: OPHTHALMIC TOPICAL THERAPEUTICS MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 20 EUROPE: OPHTHALMIC TOPICAL THERAPEUTICS MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 21 ASIA-PACIFIC: OPHTHALMIC TOPICAL THERAPEUTICS MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 22 REST OF THE WORLD: OPHTHALMIC TOPICAL THERAPEUTICS MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 23 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 24 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET

FIGURE 25 GLOBAL OPHTHALMIC TOPICAL THERAPEUTICS MARKET: COMPETITIVE LANDSCAPE

FIGURE 26 MAJOR PLAYERS SALES & OPERATING INCOME, 2022 (USD BILLION)

FIGURE 27 MAJOR PLAYERS R&D EXPENDITURE, 2022 (USD BILLION)

FIGURE 28 SANTEN PHARMACEUTICAL CO., LTD.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 SUN PHARMACEUTICAL INDUSTRIES LTD: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 NOVARTIS AG.: SWOT ANALYSIS

FIGURE 32 ABBVIE INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 33 ABBVIE INC.: SWOT ANALYSIS

FIGURE 34 BAUSCH & LOMB INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 35 BAUSCH & LOMB INCORPORATED: SWOT ANALYSIS

FIGURE 36 AMNEAL PHARMACEUTICALS LLC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 37 TEVA PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 38 TEVA PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS

FIGURE 39 ALCON: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 40 ALCON: SWOT ANALYSIS

FIGURE 41 VIATRIS INC.: FINANCIAL OVERVIEW SNAPSHOT